Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 October 2015
During its October meeting, the PRAC discussed three ongoing referrals. More information is included in the table below. The PRAC did not initiate or conclude a safety referral.
Information on all topics discussed by the PRAC is available below in the agenda for the meeting. A record of the discussions held this week will be provided in the minutes of this meeting, which will be published following the next PRAC meeting in November 2015.
Agenda
Agenda - PRAC draft agenda of meeting 5-8 October 2015
|
Product | Procedure | Status | Update in October 2015 |
|---|---|---|---|
SGLT2 inhibitors | Under evaluation | PRAC adopted a list of outstanding issues and has updated the referral timetable | |
Human papillomavirus (HPV) vaccines | Under evaluation | PRAC adopted a list of questions to the scientific advisory group | |
Tysabri | Under evaluation | PRAC continued its assessment |